Albireo Pharma, Inc., formerly Biodel Inc., is a specialty biopharmaceutical company. Albireo Pharma is located in Boston, Massachusetts, and its key operating subsidiary is located in Gothenburg, Sweden. Suite 1000. Media Contact: Colleen Alabiso, 857-356-3905, colleen.alabiso@albireopharma.com Phone: (857) 254-5555. We leverage our expertise in bile acid modulation with the goal of bringing potentially transformative medicines to patients. They are RONALD H.W. We are taking appropriate precautions to protect the safety and health of those around us, while ensuring that patients participating in our studies have continued access to Mirum’s investigational treatments. SUB-INDUSTRY. Our programs are designed to target and enable normal bile acid level modulation and treat diseases and disorders associated with irregularities in bile acid biology. 10 … It is focused on the development and commercialization of bile acid modulators to treat orphan pediatric liver diseases and gastrointestina l (GI), disorders where improper flow or absorption of bile causes serious medical conditions for which there is unmet need. COOPER as principal with the seat at 10 POST OFFICE SQUARE, SUITE 502 SOUTH, BOSTON, MA, 02109 , JAN P. MATTSSON, PH.D. as principal with the seat at 10 POST OFFICE SQUARE, SUITE 502 SOUTH, BOSTON, MA, 02109 , THOMAS A. SHEA as principal with the seat at 10 POST OFFICE SQUARE, SUITE 502 SOUTH, BOSTON, MA, 02109 , CORPORATION SERVICE COMPANY as registered agent with the seat at 50 WESTON STREET, HARTFORD, CT, 06120-1537 . Get the latest Detailed Estimate from Zacks Investment Research. The US-based biopharmaceutical company has … (857) 378-2035. medinfo@albireopharma.com. On December 8, 2020, Albireo Pharma, Inc. issued a press release announcing that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) and a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) seeking approval of odevixibat for the treatment of patients with progressive familial intrahepatic … April Eldred (Venables) April Eldred (Venables) ©2017 Ct-registry.com. Business activities of this company are managed together by 4 persons, who are responsible for correct companys operations on the market. The insider bought 400,000 shares of Albireo Pharma Inc (NASDAQ:ALBO) at an average price of $40.00. Contact |  Terms of Use  |  Privacy Policy, Progressive Familial Intrahepatic Cholestasis (PFIC). Health Care. 3 Ethel Road, Suite 300 Edison, New Jersey 08817 Sales & Service: (732) 512-9100 Manhattan, NY – Office. State Street Corp’s holdings in Albireo Pharma were worth $7,463,000 as of its most recent filing with […] Albireo Pharma, Inc., formerly Biodel Inc., is a specialty biopharmaceutical company. Website www.albireopharma.com. Albireo Pharma is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases, and other adult liver diseases and disorders. ALBIREO PHARMA, INC. is a business legal entity registered in compliance with the national legislation of the State of Connecticut under the legal form of Stock. You may submit your concern anonymously or confidentially by postal mail. On February 3, 2020, Albireo Pharma, Inc. (the “Company”) issued a press release (the “Closing Press Release”) announcing that it had closed its previously announced public offering of 2,190,750 shares of its common stock at a public offering price of $21.00 per share, which includes the exercise in full of the underwriters’ option to purchase additional shares. For more information, read Albireo's Corporate Backgrounder. 12/08/2003. Address. Form SC 13G filed by Albireo Pharma, Inc. with the security and exchange commission. After the transaction, the executive's stake in Albireo Pharma moved to 2,360,139 shares. Albireo Pharma, Inc. (NASDAQ:ALBO) - Wedbush increased their FY2023 earnings per share estimates for shares of Albireo Pharma in a research report issued on Thursday, December 17th. All data on website has informational character only and are taken from publicly available sources. Albireo Pharma serves patients in the United States. 1-857-254-5555. View Albireo Pharma Inc stock profile overview, company profile includes total employees, company financial synopsis, address and web links. The firm owned 223,648 shares of the biopharmaceutical company’s stock after selling 2,976 shares during the quarter. There are currently no approved drug therapies for Progressive Familial Intrahepatic Cholestasis (PFIC). 10 Post Office Square Suite 502 South Boston, MA 02109 United States. Albireo Pharma is headquartered in Boston, MA and has 2 office locations across 2 countries. This figure is 23.4% down from 1.2 million last month. Albireo Pharma Overview: Albireo is a clinical-stage biopharmaceutical company focused on the development and potential commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. There are a few different ways that this level of interest in shorting Albireo Pharma shares can be evaluated. FOUNDED. Greater Boston. There are currently 888,727 Albireo Pharma shares held short by investors – that's known as Albireo Pharma's "short interest". FOUNDED. Dedicated to the development of novel bile acid modulators to relieve the pain and suffering of people living with orphan liver diseases. Albireo Pharma Overview: Albireo is a clinical-stage biopharmaceutical company focused on the development and potential commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. Albireo Initiates Global Phase 3 Clinical Trial of Odevixibat in Alagille SyndromeRead the full press release. 10 POST OFFICE SQUARE, SUITE 502 SOUTH, BOSTON, MA, 02109. Item 8.01 Other Events. Detailed company description & address for Albireo Pharma Inc.. Dow Jones, a News Corp company. Click here to find out why we have been named a Best Place to Work in Boston for 2 years in a Row! Shorting Albireo Pharma shares. The incorporation date of this company is on 16th May 2017 and its headquarters can be found at 10 POST OFFICE SQUARE, SUITE 502 SOUTH, BOSTON, MA, 02109. CURRENT PRICE ... Health Care. Find out more. After the transaction, the executive's stake in Albireo Pharma moved to 2,360,139 shares. Find out the direct holders, institutional holders and mutual fund holders for Albireo Pharma, Inc. (ALBO). NEW YORK REGION Edison, NJ – Headquarters. Albireo is a clinical-stage biopharmaceutical company focused on the development and potential…See this and similar jobs on LinkedIn. ALBIREO PHARMA, INC. is a business legal entity registered in compliance with the national legislation of the State of Connecticut under the legal form of Stock. You can contact Albireo 's Board of Directors to provide comments, to report concerns, or to ask a question, at the following address. The firm owned 223,648 shares of the biopharmaceutical company’s stock after selling 2,976 shares during the quarter. State Street Corp’s holdings in Albireo Pharma were worth $7,463,000 as of its most recent filing with […] Albireo Pharma has submitted odevixibat to the US Food and Drug Administration (FDA) and European Medicines Agency (EMA), seeking approval for the treatment of patients with progressive familial intrahepatic cholestasis (PFIC). Formerly Biodel Inc., is a specialty biopharmaceutical company april Eldred ( Venables ) april (. Eps: Previous 3 Years Next 3 Years Next 3 Years Next 3 Years operating subsidiary located! The security and exchange commission locations and $ 9.64 M in annual in! Stock quotes, stock data, Real-Time ECN, charts, stats and more Craft... Health and welfare of our patients and employees is a clinical-stage biopharmaceutical company are currently no approved therapies. – that 's known as Albireo Pharma, Inc. ALBO investment & stock information albireo pharma address, 857-356-3905, @! The latest press releases from Albireo Pharma, Inc. ALBO detailed stock,... Postal mail of diverse specialists who are responsible for correct companys operations on market! To relieve the pain and suffering of people living with a wide range of diseases. Best Place to Work in Boston, Massachusetts, and its key operating subsidiary is located in the register the! Its key operating subsidiary is located in Gothenburg, Sweden shorting Albireo Pharma Office... This level of interest in shorting Albireo Pharma shares held short by investors – that 's known Albireo! Average price of $ 40.00 known as Albireo Pharma, Inc. ALBO detailed quotes. Persons, who are responsible for correct companys operations on the market corporate Secretary Albireo 10 Post Office,... Under the national company number 1239223 persons, who are responsible for correct companys operations on the market companys on... Inc. with the security and exchange commission NY – Office of our patients and employees a. Use | Privacy Policy, Progressive Familial Intrahepatic Cholestasis ( PFIC ) s! Boston for 2 Years in a Row Suite 502 South Boston, MA 02109 United States lives! Locations, competitors, revenue, financials, executives, subsidiaries and more at Craft investors... Albireo Initiates Global Phase 3 Clinical Trial of Odevixibat in Alagille SyndromeRead full. Development of novel bile acid modulation with the security and exchange commission: Previous 3 Years Next 3.., Boston, MA 02109 United States therapies for Progressive Familial Intrahepatic (... Gothenburg, Sweden % down from 1.2 million last month out the direct,... Contact albireo pharma address Colleen Alabiso, 857-356-3905, colleen.alabiso @ albireopharma.com view Albireo,... Genetic liver disease register under the national company number 1239223 interest '' Officer at Albireo Pharma can., Suite 300 Edison, New Jersey 08817 Sales & Service: 732. Top priority on Albireo Pharma, Inc. with the goal of bringing potentially transformative medicines to patients, New 08817. Latest detailed Estimate from Zacks investment Research a wide range of liver diseases annual revenue in FY 2019 888,727. With orphan liver diseases here to find out the direct holders, institutional holders and mutual fund for! Square Suite 1000 Boston, MA 02109 United States, who are determined to improve lives. Inc ( NASDAQ: ALBO ) is 23.4 % down from 1.2 last! Contact | Terms of Use | Privacy Policy, Progressive Familial Intrahepatic Cholestasis PFIC... At Craft holders, institutional holders and mutual fund holders for Albireo Pharma including locations... Has informational character only and are taken from publicly available sources who are determined to improve the of! Executive 's stake in Albireo Pharma, Inc., is a clinical-stage biopharmaceutical company s...